Perspective Therapeutics Inc (CATX)
EBITDA Margin
-31439.07%
TTM · Period ending:
CATX EBITDA Margin
Latest reported-31439.07%period ending
Latest reported-31439.07%period ending
CATX TTM EBITDA Margin (93.62% → -31439.07%)
TTM ebitda margin
High-resolution chart · PNG
CATX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -31,439.071% | |
| -19,241.5652% | |
| -11,680.4147% | |
| -12,188.4793% | |
| -14,423.5205% | |
| -12,440.4899% | |
| -12,949.9168% | |
| 965.8258% | |
| 1,616.8627% | |
| 1,674.1583% | |
| 5,443.3834% | |
| -540.4668% | |
| -462.1776% | |
| -255.3823% | |
| -116.5161% | |
| -91.154% | |
| -66.1695% | |
| -55.9364% | |
| -52.0954% | |
| -46.9657% | |
| -32.5376% | |
| -35.0759% | |
| -31.9026% | |
| -32.9367% | |
| -34.3905% | |
| -35.5818% | |
| -47.4489% | |
| -56.7993% | |
| -72.0536% | |
| -92.7213% | |
| -99.9398% | |
| -105.6901% | |
| -112.7638% | |
| -108.5237% | |
| -115.3362% | |
| -126.9475% | |
| -131.506% | |
| -123.051% | |
| -91.2868% | |
| -53.5009% | |
| -15.351% | |
| -13.8434% | |
| -33.8791% | |
| -54.427% | |
| -79.9289% | |
| -88.7205% | |
| -87.6323% | |
| -88.9597% | |
| -92.0992% | |
| -79.137% | |
| -74.2628% | |
| -76.7667% | |
| -76.3847% | |
| -68.3167% | |
| -69.9212% | |
| -62.6929% | |
| -57.5964% | |
| -53.4059% | |
| -43.4433% | |
| -50.9692% | |
| -45.2521% | |
| -54.2605% | |
| -67.165% | |
| -57.3861% | |
| -56.9802% | |
| -61.2257% | |
| -65.4717% | |
| -94.6372% | |
| -102.2118% | |
| -93.9641% | |
| -95.8847% | |
| -95.3247% | |
| -104.3186% | |
| -127.1291% | |
| -132.7161% | |
| -127.2678% | |
| -156.5795% | |
| -183.2392% | |
| -218.2665% | |
| -269.9065% | |
| -326.2054% | |
| -280.2592% | |
| -259.0591% | |
| -270.3883% | |
| 65.9566% | |
| 93.6231% |